| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
JAK1 |
|
18.930 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
PTPRB |
PTPRB, PTPB: Receptor-type tyrosine-protein phosphatase beta precursor |
18.930 |
Evidence |
|
| CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
18.930 |
Evidence |
|
| CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
18.930 |
Evidence |
|
| HOXB6 |
HOXB6, HOX2B: Homeobox protein Hox-B6 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
18.930 |
Evidence |
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
CTDP1 |
CTDP1, FCP1: RNA polymerase II subunit A C-terminal domain phosphatase |
18.930 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
PSKH1 |
PSKH1: Serine/threonine-protein kinase H1 |
18.930 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
18.930 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
SP3 |
SP3: Transcription factor Sp3 |
18.930 |
Evidence |
O
|
| INSR |
INSR: Insulin receptor precursor |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
18.930 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
18.930 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
TNC |
TNC, HXB: Tenascin precursor |
18.930 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
18.930 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
SSRP1 |
SSRP1, FACT80: FACT complex subunit SSRP1 |
18.930 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
RIN1 |
RIN1: Ras and Rab interactor 1 |
18.930 |
Evidence |
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
EHD1 |
EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 |
18.930 |
Evidence |
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
PTPN12 |
PTPN12: Tyrosine-protein phosphatase non-receptor type 12 |
18.930 |
Evidence |
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
18.930 |
Evidence |
|
| FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
18.930 |
Evidence |
|
| FOXO3A |
FOXO3A, FKHRL1: Forkhead box protein O3A |
CREBBP |
CREBBP, CBP: CREB-binding protein |
18.930 |
Evidence |
|
| NCAM2 |
NCAM2, NCAM21: Neural cell adhesion molecule 2 precursor |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
18.930 |
Evidence |
|
| HDAC3 |
HDAC3: Histone deacetylase 3 |
MEF2C |
MEF2C: Myocyte-specific enhancer factor 2C |
18.930 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
CCT2 |
CCT2, 99D8.1, CCTB: T-complex protein 1 subunit beta |
18.930 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
18.930 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
18.930 |
Evidence |
|